QA: Strongbridge Biopharma plc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001634432_2021_Strongbridge_Biopharma_plc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001634432, Strongbridge Biopharma plc

  xvar xval
0 AssetsCurrent 92,352,000
1 IntangibleAssetsNetIncludingGoodwill 27,344,000
2 PropertyPlantAndEquipmentNet 216,000
3 remainder_Assets 1,188,000
4 LiabilitiesCurrent 21,131,000
5 LiabilitiesNoncurrent 17,867,000
6 remainder_Liabilities 16,497,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 37,090,441
9 ResearchAndDevelopmentExpense 22,426,334
10 remainder_Expenses 8,234,769
11 remainder_Revenues 56,742,117
12 remainder_NetIncome 5,916,364
13 remainder_ComprehensiveNetIncome 2,999
  yvar yval
0 Assets 121,100,000
1 Liabilities 55,495,000
2 Expenses 67,751,544
3 Revenues 56,742,117
4 StockholdersEquity 65,605,000
5 NetIncome -5,093,063
6 ComprehensiveNetIncome -5,091,564
7 BaseVar 153,504,012
8 EconomicCapitalRatiobeforeLimitedLiability 1.56
9 EconomicCapitalRatio 2.72

Edgar->Model Mapping

Feature Distribution

Change over Time